Skip to main content
logo
Divi's Laboratories Limited (NSE:DIVISLAB)
India flag India · Delayed Price · Currency is INR
6,361.50
-234.00 (-3.55%)
Aug 1, 2025, 3:29 PM IST

United States Steel Revenue

In the fiscal year ending March 31, 2025, Divi's Laboratories had annual revenue of 93.60B INR with 19.31% growth. Divi's Laboratories had revenue of 25.85B in the quarter ending March 31, 2025, with 12.24% growth.

Revenue
93.60B
Revenue Growth
+19.31%
P/S Ratio
18.04
Revenue / Employee
8.88M
Employees
10,542
Market Cap
1,688.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202593.60B15.15B19.31%
Mar 31, 202478.45B780.00M1.00%
Mar 31, 202377.67B-11.93B-13.31%
Mar 31, 202289.60B19.90B28.56%
Mar 31, 202169.69B15.75B29.20%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.09B
Cipla274.80B
Mankind Pharma129.10B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Fortis Healthcare77.86B
Aurobindo Pharma317.24B
Alkem Laboratories129.65B
Revenue Rankings

Divi's Laboratories News

More News